Hymenochirin-2B
General Information
DRACP ID DRACP02296
Peptide Name Hymenochirin-2B
Sequence LKIPGFVKDTLKKVAKGIFSAVAGAMTPS
Sequence Length 29
PubChem CID Not available
Origin Hymenochirus boettgeri
Type Native peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
A549 | Lung adenocarcinoma | Carcinoma | LC50=6.9 ± 0.4 μM | CellTiter-Glo Luminescent Cell Viability assay | 24 h | 1 |
MDA-MB-231 | Breast adenocarcinoma | Carcinoma | LC50=14.6 ± 0.6 μM | CellTiter-Glo Luminescent Cell Viability assay | 24 h | 1 |
HT-29 | Colon adenocarcinoma | Carcinoma | LC50=17.7 ± 1.2 μM | CellTiter-Glo Luminescent Cell Viability assay | 24 h | 1 |
HepG2 | Hepatoblastoma | Blastoma | LC50=31.3 ± 1.9 μM | CellTiter-Glo Luminescent Cell Viability assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: LC50=210 ± 21 μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C138H232N34O36S
Absent amino acids CEHNQRWY
Common amino acids K
Mass 347525
Pl 10.98
Basic residues 5
Acidic residues 1
Hydrophobic residues 13
Net charge 4
Boman Index 176
Hydrophobicity 46.55
Aliphatic Index 97.59
Half Life
Mammalian: 20 hour
Yeast: 30 min
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 7
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 24185042
Title Anti-tumor activities of the host-defense peptide hymenochirin-1B
Doi 10.1016/j.regpep.2013.10.006
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPR_3786